Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306382012> ?p ?o ?g. }
- W4306382012 abstract "In the field of nanomedicine a multitude of nanovectors have been developed for cancer application. In this regard, a less exploited target is represented by connective tissue. Sarcoma lesions encompass a wide range of rare entities of mesenchymal origin affecting connective tissues. The extraordinary diversity and rarity of these mesenchymal tumors is reflected in their classification, grading and management which are still challenging. Although they include more than 70 histologic subtypes, the first line-treatment for advanced and metastatic sarcoma has remained unchanged in the last fifty years, excluding specific histotypes in which targeted therapy has emerged. The role of chemotherapy has not been completely elucidated and the outcomes are still very limited. At the beginning of the century, nano-sized particles clinically approved for other solid lesions were tested in these neoplasms but the results were anecdotal and the clinical benefit was not substantial. Recently, a new nanosystem formulation NBTXR3 for the treatment of sarcoma has landed in a phase 2-3 trial. The preliminary results are encouraging and could open new avenues for research in nanotechnology. This review provides an update on the recent advancements in the field of nanomedicine for sarcoma. In this regard, preclinical evidence especially focusing on the development of smart materials and drug delivery systems will be summarized. Moreover, the sarcoma patient management exploiting nanotechnology products will be summed up. Finally, an overlook on future perspectives will be provided." @default.
- W4306382012 created "2022-10-17" @default.
- W4306382012 creator A5008516429 @default.
- W4306382012 creator A5015241599 @default.
- W4306382012 creator A5016193335 @default.
- W4306382012 creator A5022603320 @default.
- W4306382012 creator A5027938879 @default.
- W4306382012 creator A5037063652 @default.
- W4306382012 creator A5038649363 @default.
- W4306382012 creator A5050243008 @default.
- W4306382012 creator A5057010377 @default.
- W4306382012 creator A5071119383 @default.
- W4306382012 creator A5073084278 @default.
- W4306382012 creator A5074249448 @default.
- W4306382012 creator A5074366864 @default.
- W4306382012 creator A5080045613 @default.
- W4306382012 creator A5081364142 @default.
- W4306382012 creator A5085363772 @default.
- W4306382012 date "2022-10-17" @default.
- W4306382012 modified "2023-10-17" @default.
- W4306382012 title "The emerging role of cancer nanotechnology in the panorama of sarcoma" @default.
- W4306382012 cites W1526057084 @default.
- W4306382012 cites W1583070060 @default.
- W4306382012 cites W1589920570 @default.
- W4306382012 cites W1859383586 @default.
- W4306382012 cites W1859924640 @default.
- W4306382012 cites W1871308790 @default.
- W4306382012 cites W1943427806 @default.
- W4306382012 cites W1955072209 @default.
- W4306382012 cites W1965495927 @default.
- W4306382012 cites W1966045502 @default.
- W4306382012 cites W1976256792 @default.
- W4306382012 cites W1977614301 @default.
- W4306382012 cites W1989230986 @default.
- W4306382012 cites W2000093612 @default.
- W4306382012 cites W2005124205 @default.
- W4306382012 cites W2009857663 @default.
- W4306382012 cites W2012978447 @default.
- W4306382012 cites W2017373675 @default.
- W4306382012 cites W2044884111 @default.
- W4306382012 cites W2045569151 @default.
- W4306382012 cites W2046351547 @default.
- W4306382012 cites W2061959862 @default.
- W4306382012 cites W2065978686 @default.
- W4306382012 cites W2073565115 @default.
- W4306382012 cites W2080176825 @default.
- W4306382012 cites W2084540402 @default.
- W4306382012 cites W2084881132 @default.
- W4306382012 cites W2091453908 @default.
- W4306382012 cites W2098217042 @default.
- W4306382012 cites W2098553441 @default.
- W4306382012 cites W2101776780 @default.
- W4306382012 cites W2106016270 @default.
- W4306382012 cites W2117326659 @default.
- W4306382012 cites W2117431699 @default.
- W4306382012 cites W2123745849 @default.
- W4306382012 cites W2136344041 @default.
- W4306382012 cites W2144642762 @default.
- W4306382012 cites W2147025403 @default.
- W4306382012 cites W2151384475 @default.
- W4306382012 cites W2155680971 @default.
- W4306382012 cites W2157342442 @default.
- W4306382012 cites W2205817527 @default.
- W4306382012 cites W2259955047 @default.
- W4306382012 cites W2341465549 @default.
- W4306382012 cites W2399461390 @default.
- W4306382012 cites W2410401920 @default.
- W4306382012 cites W2410858260 @default.
- W4306382012 cites W251900129 @default.
- W4306382012 cites W2526968623 @default.
- W4306382012 cites W2529570061 @default.
- W4306382012 cites W2531209889 @default.
- W4306382012 cites W2531231403 @default.
- W4306382012 cites W2557784336 @default.
- W4306382012 cites W2560410764 @default.
- W4306382012 cites W2562957244 @default.
- W4306382012 cites W2598830723 @default.
- W4306382012 cites W2610035536 @default.
- W4306382012 cites W2730021240 @default.
- W4306382012 cites W2735444110 @default.
- W4306382012 cites W2742019740 @default.
- W4306382012 cites W2746648325 @default.
- W4306382012 cites W2762797139 @default.
- W4306382012 cites W2766710286 @default.
- W4306382012 cites W2767805235 @default.
- W4306382012 cites W2773861321 @default.
- W4306382012 cites W277941127 @default.
- W4306382012 cites W2783070348 @default.
- W4306382012 cites W2787665771 @default.
- W4306382012 cites W2796781998 @default.
- W4306382012 cites W2800642986 @default.
- W4306382012 cites W2898356899 @default.
- W4306382012 cites W2900594661 @default.
- W4306382012 cites W2912091820 @default.
- W4306382012 cites W2952200802 @default.
- W4306382012 cites W2953678388 @default.
- W4306382012 cites W2961319233 @default.
- W4306382012 cites W2981661151 @default.
- W4306382012 cites W3012346661 @default.
- W4306382012 cites W3015954294 @default.